Neuland Laboratories Ltd (NEUL)

Currency in INR
19,156.00
-519.00(-2.64%)
Closed·
Earnings results expected tomorrow
NEUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19,155.0019,780.00
52 wk Range
11,500.0020,089.00
Key Statistics
Bid/Ask
19,155.00 / 19,239.00
Prev. Close
19,675
Open
19,650
Day's Range
19,155-19,780
52 wk Range
11,500-20,089
Volume
35.3K
Average Volume (3m)
57.16K
1-Year Change
46.419%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NEUL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Neuland Laboratories Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Goldman Sachs
Buy17,325.00-9.56%18,800.00MaintainFeb 09, 2026
Goldman Sachs
Buy19,700.00+2.84%17,225.00MaintainNov 09, 2025
Goldman Sachs
Buy17,225.00-10.08%15,425.00MaintainOct 14, 2025

Earnings

Latest Release
May 12, 2026
EPS / Forecast
165.76 / 101.75
Revenue / Forecast
7.76B / 5.74B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 283.71%
Dividend Yield
0.17%
Industry Median 0.68%
Annualized payout
34.00
Paid annually
5-Years Growth
+46.72%
Growth Streak

NEUL Income Statement

Compare NEUL to Peers and Sector

Metrics to compare
NEUL
Peers
Sector
Relationship
P/E Ratio
69.1x33.2x−0.4x
PEG Ratio
1.720.740.00
Price/Book
13.4x4.4x2.6x
Price / LTM Sales
12.4x3.6x3.0x
Upside (Analyst Target)
6.0%6.2%54.3%
Fair Value Upside
Unlock−4.6%8.4%Unlock

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, generic drug substances, as well as peptide APIs and synthesis services. The company serves generic companies, regional and domestic pharmaceutical manufacturers, distributors, and other pharmaceutical and biotechnology companies. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Employees
2183
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.78M21.69%54.74B
Other Institutional Investors
4.96M38.67%97.63B
Public Companies & Retail Investors
5.09M39.64%100.06B
Total
12.83M100.00%252.43B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Davuluri Ownership Trust25.98%3,333,35265,583,701
Malabar India Fund Limited5.65%724,73714,259,200

People Also Watch

3,230.00
ACUA
+3.65%
2,637.00
RRKA
+0.19%
1,965.00
EMCU
-0.24%
4,368.30
GETD
-0.04%
1,385.20
VIJA
+2.30%

FAQ

What Is the Neuland Laboratories (NEUL) Stock Price Today?

The Neuland Laboratories stock price today is 19,156.00 INR.

What Stock Exchange Does Neuland Laboratories Trade On?

Neuland Laboratories is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Neuland Laboratories?

The stock symbol for Neuland Laboratories is "NEUL."

Does Neuland Laboratories Pay Dividends? What’s The Current Dividend Yield?

The Neuland Laboratories dividend yield is 0.18%.

What Is the Neuland Laboratories Market Cap?

As of today, Neuland Laboratories market cap is 247.10B INR.

What Is Neuland Laboratories's Earnings Per Share (TTM)?

The Neuland Laboratories EPS (TTM) is 283.71.

When Is the Next Neuland Laboratories Earnings Date?

Neuland Laboratories will release its next earnings report on Aug 05, 2026.

From a Technical Analysis Perspective, Is NEUL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Neuland Laboratories Stock Split?

Neuland Laboratories has split 2 times.

How Many Employees Does Neuland Laboratories Have?

Neuland Laboratories has 2183 employees.

What is the current trading status of Neuland Laboratories (NEUL)?

As of Aug 04, 2026, Neuland Laboratories (NEUL) is trading at a price of 19,156.00 INR, with a previous close of 19,675.00 INR. The stock has fluctuated within a day range of 19,155.00 INR to 19,780.00 INR, while its 52-week range spans from 11,500.00 INR to 20,089.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.